Items where Author is "Decroo, T"

Journal article

LEMPENS, P., VAN DEUN, A., AUNG, K.J.M., HOSSAIN, M.A., BEHRUZNIA, M., DECROO, T., RIGOUTS, L., DE JONG, B.C. and MEEHAN, C.J., 2023. Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh. Microbial Genomics, 9 (9): 001109. ISSN 2057-5858

CUELLA-MARTIN, I., SEMUTO NGABONZIZA, J.C., TORREA, G., MEEHAN, C., MULDERS, W., USHIZIMPUMU, B., DE WEERDT, L., KEYSERS, J., DE RIJK, W.B., DECROO, T., DE JONG, B.C. and RIGOUTS, L., 2023. Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda. International Journal of Mycobacteriology, 12 (3), pp. 274-281. ISSN 2212-5531

NGABONZIZA, J.C.S., RIGOUTS, L., TORREA, G., DECROO, T., KAMANZI, E., LEMPENS, P., RUCOGOZA, A., HABIMANA, Y.M., LAENEN, L., NIYIGENA, B.E., UWIZEYE, C., USHIZIMPUMU, B., MULDERS, W., IVAN, E., TZFADIA, O., MUVUNYI, C.M., MIGAMBI, P., ANDRE, E., MAZARATI, J.B., AFFOLABI, D., UMUBYEYI, A.N., NSANZIMANA, S., PORTAELS, F., GASANA, M., DE JONG, B.C. and MEEHAN, C.J., 2022. Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 27: 100299.

LEMPENS, P., DECROO, T., AUNG, K.J.M., HOSSAIN, M.A., RIGOUTS, L., MEEHAN, C.J., VAN DEUN, A. and DE JONG, B.C., 2020. Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen. International Journal of Infectious Diseases, 100, pp. 357-365. ISSN 1201-9712

NGABONZIZA, J.C.S., DECROO, T., MIGAMBI, P., HABIMANA, Y.M., VAN DEUN, A., MEEHAN, C.J., TORREA, G., MASSOU, F., DE RIJK, W.B., USHIZIMPUMU, B., NIYIGENA, E.B., IVAN, E., SEMAHORE, J.M., MAZARATI, J.B., MERLE, C.S., SUPPLY, P., AFFOLABI, D., RIGOUTS, L. and DE JONG, B.C., 2020. Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda. The Lancet Microbe, 1 (2), e74-e83. ISSN 2666-5247

NGABONZIZA, S., HABIMANA, Y.M., DECROO, T., MIGAMBI, P., DUSHIME, A., MAZARATI, J.B., RIGOUTS, L., AFFOLABI, D., IVAN, E., MEEHAN, C.J., VAN DEUN, A., FISSETTE, K., HABIYAMBERE, I., NYARUHIRIRA, A.U., TURATE, I., SEMAHORE, J.M., NDJEKA, N., MUVUNYI, C.M., CONDO, J.U., GASANA, M., HASKER, E., TORREA, G. and DE JONG, B.C., 2020. Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda. International Journal of Tuberculosis and Lung Disease, 24 (3), pp. 329-339. ISSN 1027-3719